CETAX
Price
$12.61
Change
-$0.14 (-1.10%)
Updated
Apr 3 closing price
Net Assets
75.11M
RIRAX
Price
$71.22
Change
-$1.21 (-1.67%)
Updated
Apr 3 closing price
Net Assets
109.78B
Ad is loading...

CETAX vs RIRAX

Header iconCETAX vs RIRAX Comparison
Open Charts CETAX vs RIRAXBanner chart's image
Centerstone Investors A
Price$12.61
Change-$0.14 (-1.10%)
VolumeN/A
Net Assets75.11M
American Funds Capital Income Bldr R1
Price$71.22
Change-$1.21 (-1.67%)
VolumeN/A
Net Assets109.78B
CETAX vs RIRAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CETAX vs. RIRAX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CETAX is a Hold and RIRAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RIRAX has more cash in the bank: 110B vs. CETAX (75.1M). RIRAX pays higher dividends than CETAX: RIRAX (2.40) vs CETAX (1.94). CETAX was incepted earlier than RIRAX: CETAX (9 years) vs RIRAX (23 years). CETAX (1.49) is less costly to investors than RIRAX (1.36). RIRAX has a lower initial minimum investment than CETAX: RIRAX (250) vs CETAX (2500). RIRAX annual gain was more profitable for investors over the last year : 7.55 vs. CETAX (3.15). CETAX return over 5 years is better than : 62.14 vs. RIRAX (50.02).
CETAXRIRAXCETAX / RIRAX
Total Expense Ratio1.421.36104%
Annual Report Gross Expense Ratio1.491.36110%
Fund Existence9 years23 years-
Gain YTD7.9593.533225%
Front Load5%N/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets75.1M110B0%
Annual Yield % from dividends1.942.4081%
Returns for 1 year3.157.5542%
Returns for 3 years3.529.7136%
Returns for 5 years62.1450.02124%
Returns for 10 yearsN/A32.08-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RTC0.23N/A
-0.09%
Baijiayun Group Ltd
ENR29.35-0.62
-2.07%
Energizer Holdings
BDRX1.47-0.07
-4.55%
Biodexa Pharmaceuticals plc
NAGE6.63-0.45
-6.36%
Niagen Bioscience Inc
ONTO109.83-15.60
-12.44%
Onto Innovation